 Proto-Oncogene Proteins c-bcl-6
"Proto-Oncogene Proteins c-bcl-6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A DNA-binding protein that represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA.
| Descriptor ID |
D051560
|
| MeSH Number(s) |
D12.776.260.660 D12.776.624.664.700.170 D12.776.930.633
|
| Concept/Terms |
Proto-Oncogene Proteins c-bcl-6- Proto-Oncogene Proteins c-bcl-6
- Proto Oncogene Proteins c bcl 6
- c-bcl-6, Proto-Oncogene Proteins
- bcl-6 Proto-Oncogene Proteins
- Proto-Oncogene Proteins, bcl-6
- bcl 6 Proto Oncogene Proteins
- Zinc Finger Protein 51
- c-bcl-6 Proto-Oncogene Proteins
- Proto-Oncogene Proteins, c-bcl-6
- c bcl 6 Proto Oncogene Proteins
- Proto-Oncogene Protein bcl-6
- Proto Oncogene Protein bcl 6
- bcl-6, Proto-Oncogene Protein
- Proto-Oncogene Protein c-bcl-6
- Proto Oncogene Protein c bcl 6
- B-Cell Lymphoma 6 Protein
- B Cell Lymphoma 6 Protein
- c-bcl-6 Protein
- c bcl 6 Protein
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-bcl-6".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-bcl-6".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-bcl-6" by people in UAMS Profiles by year, and whether "Proto-Oncogene Proteins c-bcl-6" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 | | 2018 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-bcl-6" by people in Profiles over the past ten years.
-
Pina-Oviedo S, Bellamy WT, Gokden M. Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases. Ann Diagn Pathol. 2020 Oct; 48:151610.
-
Saad AG, Grada Z, Bishop B, Abulsayen H, Hassan M, Firpo-Betancourt A, Teruya-Feldstein J, Fraig M, El Jamal SM. nCounter NanoString Assay Shows Variable Concordance With Immunohistochemistry-based Algorithms in Classifying Cases of Diffuse Large B-Cell Lymphoma According to the Cell-of-Origin. Appl Immunohistochem Mol Morphol. 2019 10; 27(9):644-648.
-
El Jamal SM, Grada Z, El Dinali MH, Zhou H, Hassan SY, Saad AG, Gibson B, Zhou X, Abulsayen HA, Khadra HS, Friedman J, Shalaby H, Kadi A, Megahed M, Emberesh M, Teruya-Feldstein J, Firpo-Betancourt A, Haikel Y, Fraig M, Hassan M. MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type. Lab Invest. 2019 04; 99(4):539-550.
-
Caponetti GC, Dave BJ, Perry AM, Smith LM, Jain S, Meyer PN, Bast M, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Aoun P, Fu K, Greiner TC, Chan WC, Sanger WG, Weisenburger DD. Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome. Leuk Lymphoma. 2015; 56(11):3082-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|